Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carboplatin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07098988
What this trial is testing

Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC

Who this might be right for
Metastatic Non-Squamous Non-Small Cell Lung CancerAdult Solid Tumor
CatalYm GmbH 107
Testing effectiveness (Phase 2)UnknownNCT04725448
What this trial is testing

Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma

Who this might be right for
Pulmonary Sarcomatoid CarcinomaNon-small Cell Lung CancerLung Diseases+1 more
Sichuan Cancer Hospital and Research Institute 27
Early research (Phase 1)Study completedNCT00004082
What this trial is testing

Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors

Who this might be right for
Endometrial CancerFallopian Tube CancerOvarian Cancer+1 more
Beth Israel Deaconess Medical Center
Testing effectiveness (Phase 2)Study completedNCT00193297
What this trial is testing

Topotecan Plus Paclitaxel and Carboplatin in the Initial Treatment of Advanced Ovarian and Primary Peritoneal Carcinoma

Who this might be right for
Ovary Cancer
SCRI Development Innovations, LLC 50
Not applicableActive Not RecruitingNCT01928589
What this trial is testing

Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer

Who this might be right for
Breast CancerAdenocarcinoma of the Breast
Richard Zellars 81
Large-scale testing (Phase 3)UnknownNCT00112710
What this trial is testing

Gemcitabine in Combination With Either Cisplatin or Carboplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University Hospital Birmingham 1,350
Testing effectiveness (Phase 2)Study completedNCT02499770
What this trial is testing

Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Cancer
G1 Therapeutics, Inc. 122
Early research (Phase 1)Active Not RecruitingNCT01959698
What this trial is testing

Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma

Who this might be right for
CD20 PositiveRecurrent Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma+4 more
Roswell Park Cancer Institute 29
Testing effectiveness (Phase 2)Study completedNCT00004201
What this trial is testing

Gemcitabine Plus Carboplatin or Cisplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Herbert Irving Comprehensive Cancer Center
Testing effectiveness (Phase 2)UnknownNCT00635557
What this trial is testing

Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Myrexis Inc. 30
Testing effectiveness (Phase 2)Study completedNCT01075100
What this trial is testing

Ixabepilone + Carboplatin Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
US Oncology Research 103
Testing effectiveness (Phase 2)Ended earlyNCT03645928
What this trial is testing

Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

Who this might be right for
Metastatic MelanomaSquamous Cell Carcinoma of the Head and NeckNon-small Cell Lung Cancer
Iovance Biotherapeutics, Inc. 225
Large-scale testing (Phase 3)Study completedNCT03875092
What this trial is testing

Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407)-China Extension Study

Who this might be right for
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 125
Testing effectiveness (Phase 2)Study completedNCT00654836
What this trial is testing

Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Loyola University 32
Early research (Phase 1)Study completedNCT00249964
What this trial is testing

Combination Paclitaxel, Carboplatin and Temozolomide

Who this might be right for
Lung DiseasesCancer
New Mexico Cancer Research Alliance 15
Testing effectiveness (Phase 2)WithdrawnNCT03699033
What this trial is testing

Hypofractionated Radiotherapy With Carboplatin and Paclitaxel in Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Stephanie Smiddy
Testing effectiveness (Phase 2)Study completedNCT00753909
What this trial is testing

Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 50
Testing effectiveness (Phase 2)Looking for participantsNCT06755684
What this trial is testing

Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-advanced EGFR Mutation-positive Non-Small Cell Lung Cancer

Who this might be right for
EGFRNon-Small Cell Lung CancerLocally Advanced Non-Small Cell Lung Cancer+5 more
Peng Zhang 60
Testing effectiveness (Phase 2)UnknownNCT04739670
What this trial is testing

Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Breast Cancer

Who this might be right for
Metastatic Triple Negative Breast Cancer
Peter MacCallum Cancer Centre, Australia 31
Testing effectiveness (Phase 2)Study completedNCT01248962
What this trial is testing

Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Memorial Sloan Kettering Cancer Center 146
Next Page